Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T03:40:11.742Z Has data issue: false hasContentIssue false
  • English
  • Français

Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists

Published online by Cambridge University Press:  02 January 2018

Danyael Lutgens ,
Martin Lepage ,
Rahul Manchanda  and
Ashok Malla
Danyael Lutgens
Affiliation:
McGill University Department of Psychiatry Prevention and Early Intervention Program for the Psychoses, Douglas Mental Health University Institute, Montreal, Quebec, Canada
Martin Lepage
Affiliation:
Department of Psychiatry, McGill University, Montreal, Quebec Prevention and Early Intervention Program for the Psychoses, Douglas Mental Health University Institute, Montreal, Quebec, Canada
Rahul Manchanda
Affiliation:
Department of Psychiatry, Western University, Ontario Prevention and Early Intervention Program for the Psychoses, London Health Sciences Centre, London, Ontario, Canada
Ashok Malla
Affiliation:
Department of Psychiatry, McGill University, Montreal, Quebec Prevention and Early Intervention Program for the Psychoses, Douglas Mental Health University Institute, Montreal, Quebec, Canada, email [email protected]
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A sample of 206 Canadian psychiatrists who routinely treat patients with psychotic disorders were randomly surveyed regarding their knowledge and practice in relation to persistent negative symptoms of schizophrenia. Large majorities reported observing a high prevalence of persistent negative symptoms that do not respond to available treatments (83%), have a profound impact on functional outcomes (96.5%) and contribute to family burden. Almost half the sample (43%) recognised the importance of formally assessing persistent symptoms and nearly a third (30%) indicated that this was a part of their usual practice. These survey results correspond with recent consensus and highlight the importance and challenge of treating persistent negative symptoms in schizophrenia.

Type
Research Papers
Information
International Psychiatry , Volume 10 , Issue 3 , August 2013 , pp. 69 - 72
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2013

References

Andreasen, N. C. & Olsen, S. (1982) Negative v positive schizophrenia: definition and validation. Archives of General Psychiatry, 39, 789.Google Scholar
Barnes, T. R. & Paton, C. (2011) Do antidepressants improve negative symptoms in schizophrenia? BMJ, 342, d3371.CrossRefGoogle ScholarPubMed
Bow-Thomas, C. C., Velligan, D. I., Miller, A. L., et al (1999) Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Research, 86, 131–142.Google Scholar
Buchanan, R. W. (2007) Persistent negative symptoms in schizophrenia: an overview. Schizophrenia Bulletin, 33, 1013–1022.CrossRefGoogle ScholarPubMed
Cassidy, C. M., Lepage, M., Harvey, P. O., et al (2012) Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls. Schizophrenia Research, 137, 39–44.Google Scholar
Corcoran, C., Kimhy, D., Parrilla-Escobar, M., et al (2011) The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine, 41, 251–261.Google Scholar
Foussias, G., Mann, S., Zakzanis, K., et al (2009) Motivational deficits as the central link to functioning in schizophrenia: a pilot study. Schizophrenia Research, 115, 333–337.Google Scholar
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., et al (2006) The NIMH MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin, 32, 214–219.CrossRefGoogle ScholarPubMed
Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., et al (2004) The Schizophrenia Patient Outcomes Research Team (PORT). Schizophrenia Bulletin, 30, 193–217.CrossRefGoogle ScholarPubMed
Malla, A. K., Norman, R., Manchanda, R., et al (2002) One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia Research, 54, 231.Google Scholar
Malla, A. K., Bodnar, M., Joober, R., et al (2011) Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophrenia Research, 125, 13–20.Google Scholar
Milev, P., Ho, B. C., Arndt, S., et al (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry, 162, 495–506.Google Scholar
Möller, H. J. (2003) Management of the negative symptoms of schizophrenia. CNS Drugs, 17, 793–823.Google Scholar
Möller, H. J. (2007) Clinical evaluation of negative symptoms in schizophrenia. European Psychiatry, 22, 380–386.Google Scholar
Perlick, D., Rosenheck, R., Kaczynski, R., et al (2006) Special section on CATIE baseline data: components and correlates of family burden in schizophrenia. Psychiatric Services, 57, 1117–1125.Google Scholar
Rector, N. A. & Beck, A. T. (2001) Cognitive behavioral therapy for schizophrenia: an empirical review. Journal of Nervous and Mental Disease, 189, 278–287.Google Scholar
Wykes, T., Steel, C. & Everitt, B. (2008) Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34, 523–537.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.